Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 3
2011 2
2012 1
2013 9
2014 10
2015 10
2016 9
2017 22
2018 19
2019 16
2020 14
2021 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Adalsteinsson VA, Ha G, Freeman SS, Choudhury AD, Stover DG, Parsons HA, Gydush G, Reed SC, Rotem D, Rhoades J, Loginov D, Livitz D, Rosebrock D, Leshchiner I, Kim J, Stewart C, Rosenberg M, Francis JM, Zhang CZ, Cohen O, Oh C, Ding H, Polak P, Lloyd M, Mahmud S, Helvie K, Merrill MS, Santiago RA, O'Connor EP, Jeong SH, Leeson R, Barry RM, Kramkowski JF, Zhang Z, Polacek L, Lohr JG, Schleicher M, Lipscomb E, Saltzman A, Oliver NM, Marini L, Waks AG, Harshman LC, Tolaney SM, Van Allen EM, Winer EP, Lin NU, Nakabayashi M, Taplin ME, Johannessen CM, Garraway LA, Golub TR, Boehm JS, Wagle N, Getz G, Love JC, Meyerson M. Adalsteinsson VA, et al. Among authors: harshman lc. Nat Commun. 2017 Nov 6;8(1):1324. doi: 10.1038/s41467-017-00965-y. Nat Commun. 2017. PMID: 29109393 Free PMC article.
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY, Xie W, Regan MM, Harshman LC, Bjarnason GA, Vaishampayan UN, Mackenzie M, Wood L, Donskov F, Tan MH, Rha SY, Agarwal N, Kollmannsberger C, Rini BI, Choueiri TK. Heng DY, et al. Among authors: harshman lc. Lancet Oncol. 2013 Feb;14(2):141-8. doi: 10.1016/S1470-2045(12)70559-4. Epub 2013 Jan 9. Lancet Oncol. 2013. PMID: 23312463 Free PMC article.
Risk Assessment in Small Renal Masses: A Review Article.
Sun M, Vetterlein M, Harshman LC, Chang SL, Choueiri TK, Trinh QD. Sun M, et al. Among authors: harshman lc. Urol Clin North Am. 2017 May;44(2):189-202. doi: 10.1016/j.ucl.2016.12.005. Urol Clin North Am. 2017. PMID: 28411911 Review.
Non-clear cell renal cell carcinoma, part 1: histology.
Valenca LB, Hirsch MS, Choueiri TK, Harshman LC. Valenca LB, et al. Among authors: harshman lc. Clin Adv Hematol Oncol. 2015 May;13(5):308-13. Clin Adv Hematol Oncol. 2015. PMID: 26352775 Review.
Second-line therapies in metastatic urothelial carcinoma.
Narayanan S, Harshman LC, Srinivas S. Narayanan S, et al. Among authors: harshman lc. Hematol Oncol Clin North Am. 2015 Apr;29(2):341-59, x. doi: 10.1016/j.hoc.2014.10.007. Epub 2015 Jan 28. Hematol Oncol Clin North Am. 2015. PMID: 25836939 Review.
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Saliby RM, El Zarif T, Bakouny Z, Shah V, Xie W, Flippot R, Denize T, Kane MH, Madsen KN, Ficial M, Hirsch L, Wei XX, Steinharter JA, Harshman LC, Vaishampayan UN, Severgnini M, McDermott DF, Lee GM, Xu W, Van Allen EM, McGregor BA, Signoretti S, Choueiri TK, McKay RR, Braun DA. Saliby RM, et al. Among authors: harshman lc. Cancer Immunol Res. 2023 Aug 3;11(8):1114-1124. doi: 10.1158/2326-6066.CIR-22-0996. Cancer Immunol Res. 2023. PMID: 37279009 Free PMC article.
105 results